Earnings summaries and quarterly performance for American Healthcare REIT.
Executive leadership at American Healthcare REIT.
Board of directors at American Healthcare REIT.
Brian Flornes
Detailed
Independent Director
Dianne Hurley
Detailed
Independent Director
Jeffrey Hanson
Detailed
Non-Executive Chairman
Marvin O’Quinn
Detailed
Independent Director
Mathieu Streiff
Detailed
Director
Scott Estes
Detailed
Independent Director
Valerie Richardson
Detailed
Independent Director
Wilbur Smith III
Detailed
Independent Director
Research analysts who have asked questions during American Healthcare REIT earnings calls.
Austin Wurschmidt
KeyBanc Capital Markets Inc.
9 questions for AHR
Also covers: AIV, AMH, APLE +20 more
Ronald Kamdem
Morgan Stanley
9 questions for AHR
Also covers: AAT, ADC, ALX +36 more
Farrell Granath
Bank of America
8 questions for AHR
Also covers: ADC, ARE, CTRE +13 more
Michael Carroll
RBC Capital Markets
7 questions for AHR
Also covers: ARE, COLD, CTRE +16 more
Seth Bergey
Citi
7 questions for AHR
Also covers: BDN, CBRE, CDP +15 more
Michael Stroyeck
Green Street Advisors, LLC
4 questions for AHR
Also covers: DOC, OHI, SBRA +1 more
Nicholas Yulico
Scotiabank
4 questions for AHR
Also covers: ALX, AVB, BXP +20 more
Wesley Golladay
Robert W. Baird & Co.
4 questions for AHR
Also covers: ADC, ARE, CPT +23 more
Alex Fagan
Robert W. Baird & Co. Incorporated
2 questions for AHR
Also covers: PINE
Michael Dahl
RBC Capital Markets
2 questions for AHR
Also covers: AZEK, BECN, BLDR +20 more
Michael Goldsmith
UBS
2 questions for AHR
Also covers: ADC, AMH, AVB +33 more
Michael Griffin
Citigroup Inc.
2 questions for AHR
Also covers: ALX, ARE, BDN +32 more
Joseph Dickstein
Jefferies
1 question for AHR
Also covers: OHI
Joshua Dennerlein
BofA Securities
1 question for AHR
Also covers: AMH, ARE, AVB +18 more
Recent press releases and 8-K filings for AHR.
American Healthcare REIT, Inc. completes public offering and forward sale agreement for additional shares
AHR
New Projects/Investments
- American Healthcare REIT, Inc. (AHR) closed a public offering of 8,100,000 shares of common stock on November 24, 2025.
- On the same date, the underwriter fully exercised its option to purchase an additional 1,215,000 shares of common stock.
- An Additional Forward Sale Agreement was executed for these 1,215,000 shares, with an initial forward price of $47.75 per share.
- AHR intends to physically settle this agreement by May 20, 2027, and use the net proceeds for general corporate purposes, including potential future investments.
Nov 26, 2025, 9:16 PM
American Healthcare REIT Prices Public Offering of Common Stock
AHR
New Projects/Investments
- American Healthcare REIT, Inc. (AHR) announced the pricing of an underwritten public offering of 8,100,000 shares of its common stock.
- The aggregate gross proceeds to the Company from the offering are expected to be approximately $388.8 million.
- The offering is anticipated to close on November 24, 2025.
- The Company expects to use the net proceeds from the settlement of the forward sale agreement for general corporate purposes, including potential future investments.
Nov 21, 2025, 4:05 AM
AHR Reports Strong Q3 2025 Results and Raises Full-Year Guidance
AHR
Earnings
Guidance Update
New Projects/Investments
- AHR reported normalized FFO per fully diluted share of $0.44 in Q3 2025, a 22% increase year-over-year.
- The company achieved 16.4% same-store NOI growth across its total portfolio, marking its seventh consecutive quarter of double-digit growth.
- AHR raised its full-year 2025 NFFO guidance to a range of $1.69-$1.72 per fully diluted share, implying growth over 20% year-over-year at the midpoint.
- Year-to-date acquisitions exceeded $575 million, with an additional pipeline of awarded deals over $450 million expected to close by early 2026.
- Net debt to EBITDA improved to 3.5 times at the end of Q3 2025.
Nov 7, 2025, 6:00 PM
American Healthcare REIT, Inc. Announces Strong Q3 2025 Results and Increases Full Year 2025 Guidance
AHR
Earnings
Guidance Update
New Projects/Investments
- American Healthcare REIT, Inc. reported GAAP net income attributable to controlling interest of $55.9 million, or $0.33 per diluted share, and Normalized Funds from Operations (NFFO) of $0.44 per diluted share for the third quarter ended September 30, 2025.
- The company achieved a total portfolio Same-Store Net Operating Income (NOI) growth of 16.4% for the three months ended September 30, 2025, compared to the same period in 2024.
- AHR increased its full-year 2025 guidance for total portfolio Same-Store NOI growth to a revised range of 13.0% to 15.0% and NFFO per diluted share to a revised range of $1.69 to $1.72.
- During the third quarter of 2025, the company closed approximately $210.8 million in acquisitions, bringing year-to-date 2025 acquisitions to over $575 million.
Nov 6, 2025, 10:07 PM
American Healthcare REIT (AHR) Announces Q3 2025 Results and Increases Full Year 2025 Guidance
AHR
Earnings
Guidance Update
M&A
- American Healthcare REIT (AHR) reported GAAP net income attributable to controlling interest of $55.9 million, or $0.33 per diluted share, and Normalized Funds from Operations (NFFO) of $0.44 per diluted share for the three months ended September 30, 2025.
- The company achieved strong operational growth, with total portfolio Same-Store Net Operating Income (NOI) growth of 16.4% for the three months ended September 30, 2025, compared to the same period in 2024.
- AHR has increased its full year 2025 guidance for NFFO per diluted share to a revised range of $1.69 to $1.72 (midpoint $1.71) and for total portfolio Same-Store NOI growth to 13.0% to 15.0% (midpoint 14.0%).
- During the third quarter of 2025, AHR closed on approximately $210.8 million of acquisitions and issued common stock for gross proceeds of approximately $244.1 million through equity offerings.
- The company also reported an improvement in its leverage metric, with Net Debt-to-Annualized Adjusted EBITDA decreasing to 3.5x as of September 30, 2025, from 3.7x as of June 30, 2025.
Nov 6, 2025, 9:15 PM
American Healthcare REIT Discusses Strong Operating Environment and Growth Strategy
AHR
New Projects/Investments
Revenue Acceleration/Inflection
Guidance Update
- President and CEO Danny Prosky stated that the current period is the best operating environment he has seen in 33 years, with outsized organic earnings growth for REITs like American Healthcare REIT due to demand for long-term care outpacing supply, a trend expected to continue for 15 years.
- Spot occupancy for American Healthcare REIT was approximately 87.5% at the end of the second quarter, with very strong growth observed in July and August. The company is shifting its focus towards revenue per occupied bed (REVPOR) growth as occupancy increases, reducing incentives.
- Trilogy, which accounts for more than half of American Healthcare REIT's Net Operating Income (NOI), has converted its long-term incentive plan (LTIP) to stock-based compensation effective January 1, 2024, to align incentives with overall company performance. Trilogy's employee turnover is significantly lower than the industry average, at 40% to 45% annually compared to 80% to 100%.
- The current acquisition pipeline of awarded transactions is over $350 million. American Healthcare REIT anticipates strong earnings growth from its existing portfolio even without new acquisitions, but plans to continue external growth. Underwriting assumptions for acquisitions are considered too conservative, with a 3% rent growth assumption.
Sep 10, 2025, 8:30 PM
American Healthcare REIT Discusses Strong Operating Environment and Growth Strategy
AHR
M&A
New Projects/Investments
Revenue Acceleration/Inflection
- American Healthcare REIT (AHR) President and CEO Danny Prosky describes the current operating environment as the best he has seen in 33 years, anticipating continued demand growth for long-term care for the next 15 years due to the aging baby boomer population and limited new supply.
- AHR reported spot occupancy of approximately 87.5% at the end of the second quarter, with strong acceleration observed in July and August.
- The company now owns 100% of Trilogy, which contributes over half of its NOI, and has aligned Trilogy's long-term incentive plan (LTIP) with overall AHR performance, effective January 1, 2024.
- AHR's acquisition pipeline includes over $350 million in awarded transactions, focusing on newer, high-quality assets to drive future organic earnings growth.
- Underwriting assumptions for acquisitions are considered conservative, with rent growth projected at 3%, suggesting potential for outperformance.
Sep 10, 2025, 8:30 PM
American Healthcare REIT Discusses Strong Operating Environment and Growth Strategy
AHR
New Projects/Investments
Revenue Acceleration/Inflection
- American Healthcare REIT (AHR) President and CEO Danny Prosky described the current operating environment as the best he has seen in 33 years, driven by an imbalance between supply and demand for long-term care, with baby boomers starting to turn 80 next year.
- AHR's spot occupancy was approximately 87.5% at the end of the second quarter, with strong growth observed in July and August. The company is increasingly focusing on revenue per occupied bed (REVPOR) growth over just occupancy, implementing strategies like dynamic pricing.
- Trilogy, which accounts for more than half of AHR's NOI, is an integrated senior health campus model, and AHR now owns 100% of it. Trilogy's employee turnover is significantly lower than the industry average, at 40%-45% compared to 80%-100%.
- AHR's acquisition pipeline currently stands at over $350 million in awarded transactions, with a focus on newer, higher-quality assets that are expected to drive organic earnings growth. The company also plans to invest approximately $150 million annually in Trilogy development, including 2-4 new campuses per year.
Sep 10, 2025, 8:30 PM
Quarterly earnings call transcripts for American Healthcare REIT.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more